Report Date: December 7, 2025
Analysis Horizon: 10-Day Trading (Dec 9-19, 2025)
Current Price: $181.76
Proposed Allocation: 49.7% ($728 for 4 shares)
PLTR presents a rare and dangerous investment paradox:
This is a beautiful company at a terrible price.
Key Reasons:
Official Classification: SPECULATION
Defensive Investor Scorecard: 3/7 criteria passed
Failed criteria:
| Metric | Graham Approach | Value | Result |
|---|---|---|---|
| Graham Number | √(22.5 × EPS × Book Value) | $5.02 | 3,621% OVERVALUED |
| Earnings Yield | Current P/E inverse | 0.24% | Requires 6%+ for safety |
| Intrinsic Value | EPS × (8.5 + 2g) | $3.87-4.00 | 4,544% OVERVALUED |
| Fair Value | DCF @ risk-adjusted rate | $6.62 | 2,643% OVERVALUED |
Verdict: Fundamentally indefensible at any time horizon
PLTR is NOT broken. The business is accelerating:
Business Quality Grade: 9/10
The problem is NOT the business. The problem is the price.
Technical Strengths:
Fundamental Reality:
Conclusion: Technical strength is illusory. Fundamentals will reassert gravity.
FOMC meeting on Day 7 is a critical uncontrollable risk:
PLTR's Beta: 1.50 (50% more volatile than SPY)
Expected impact by outcome:
Result: Single event could erase entire 10-day gains AND trigger losses.
| Risk Type | Level | Comment |
|---|---|---|
| Valuation Risk | EXTREME (9/10) | Unsustainable P/E 413 |
| Business Risk | LOW (2/10) | Fundamentals solid |
| Macro Risk | EXTREME (9/10) | FOMC event Dec 17 |
| Technical Risk | MEDIUM (6/10) | Overbought short-term |
| Aggregate Risk | EXTREME | Unfavorable risk/reward |
Proposed allocation: 49.7% ($728)
This is EXCESSIVE for this valuation risk:
Beta-adjusted exposure:
$728 position × 1.50 beta = $1,092 notional market risk
Portfolio downside: 15% FOMC move = -$109 loss
Expected 10-day upside: 5% move = +$36 gain
Risk/Reward ratio: 1.50:1 NEGATIVE (should be ≥2:1 for aggression)
Maximum defensible allocation: 20% ($146)
Reasoning:
Trade Rules:
Expected Value Calculation:
(35% prob of +7%) + (40% prob of +2%) + (25% prob of -9%)
= +2.45% + 0.80% - 2.25%
= +1.1% expected return
For 20% position: 0.2 × 1.1% = 0.22% portfolio impact
NOT worth the concentration risk.
From The Intelligent Investor on growth stocks:
"For such favored issues the market has a tendency to set prices that will not be adequately protected by a conservative projection of future earnings. The margin of safety is always dependent on the price paid. It will be large at one price, small at some higher price, nonexistent at some still higher price."
PLTR Application: At P/E 413, we are at "nonexistent margin of safety" price.
Historical precedent for 400+ P/E stocks:
Pattern: Ultra-high P/E stocks face 50-70% crash risk when sentiment shifts.
With FOMC decision looming, sentiment could shift Dec 17.
| Dimension | Score | Assessment |
|---|---|---|
| Business Quality | A+ | Excellent fundamentals |
| Revenue Growth | 5/5 | Exceptional 47%+ YoY |
| Profitability | 5/5 | 32.6% net margin |
| Balance Sheet | 5/5 | $5.8B net cash |
| Valuation | F-- | 413x P/E indefensible |
| Margin of Safety | F-- | -4,444% negative |
| 10-Day Risk/Reward | UNFAV | Downside > upside |
| Graham Compliance | FAIL | 3/7 criteria only |
Overall Assessment: AVOID
PLTR is a beautiful company at an ugly price. The business fundamentals are genuinely excellent and accelerating. However, at P/E 413:
Classification: SPECULATION (not investment)
Recommendation: STRONG AVOID
Confidence: HIGH (90%)
If forced to trade: Maximum 20% allocation with hard stops
The fundamental analysis is clear: Avoid this trade or significantly reduce exposure.